|
OSGIN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.414600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.247200E-01 |
| Normal-vs-Stage2 |
7.630200E-01 |
| Normal-vs-Stage3 |
6.344000E-01 |
| Normal-vs-Stage4 |
6.184200E-01 |
| Stage1-vs-Stage2 |
8.819000E-01 |
| Stage1-vs-Stage3 |
4.982000E-01 |
| Stage1-vs-Stage4 |
7.606600E-01 |
| Stage2-vs-Stage3 |
5.823000E-01 |
| Stage2-vs-Stage4 |
9.627800E-01 |
| Stage3-vs-Stage4 |
4.490000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.264600E-01 |
| Normal-vs-AfricanAmerican |
7.236500E-02 |
| Normal-vs-Asian |
4.223800E-01 |
| Caucasian-vs-AfricanAmerican |
5.751700E-02 |
| Caucasian-vs-Asian |
4.254600E-01 |
| AfricanAmerican-vs-Asian |
3.347000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.412200E-01 |
| Normal-vs-Female |
1.594170E-01 |
| Male-vs-Female |
4.858400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.662800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.325200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.576600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.777200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.902200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.127400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.564400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.388600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.984000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.223200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.238400E-01 |
| Normal-vs-Grade 2 |
4.014800E-01 |
| Normal-vs-Grade 3 |
2.939000E-01 |
| Normal-vs-Grade 4 |
9.676400E-01 |
| Grade 1-vs-Grade 2 |
6.646200E-01 |
| Grade 1-vs-Grade 3 |
2.752600E-01 |
| Grade 1-vs-Grade 4 |
6.195000E-01 |
| Grade 2-vs-Grade 3 |
8.724400E-02 |
| Grade 2-vs-Grade 4 |
6.972600E-01 |
| Grade 3-vs-Grade 4 |
5.694400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.463400E-01 |
| Normal-vs-ccB subtype |
7.100200E-01 |
| ccA subtype-vs-ccB subtype |
8.080000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.434000E-01 |
| Normal-vs-N1 |
4.834800E-01 |
| N0-vs-N1 |
5.074200E-01 |
|
|
